alirocumab
Drug timelines are a Plus or Pro feature.
46 regulatory and trial events tracked for alirocumab, covering 2013-06-28 to 2026-08-18. Get the full timeline:
Most recent: Clinical Trial Results: Cardiac Allograft Vasculopathy Inhibition With Alirocumab [Phase 2]